Aptamer-conjugated liposome system for targeting MUC1-positive cancer: an in silico screening approach

被引:0
|
作者
Md Shakil Ahmed Khan [1 ]
Jiwoo Park [1 ]
Somin Lee [1 ]
Jee-Eun Hwang [1 ]
Chiwoo Oh [2 ]
MinKyu Kim [2 ]
Jeong-Seob Lee [2 ]
Jongyeong Jeon [1 ]
Beomjin Park [1 ]
Shengjun Li [1 ]
Han Na Jung [2 ]
Hyung-Jun Im [1 ]
机构
[1] Seoul National University,Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology
[2] Seoul National University,Department of Applied Bioengineering, Graduate School of Convergence Science and Technology
[3] Cancer Research Institute,undefined
[4] Seoul National University,undefined
[5] Research Institute for Convergence Science,undefined
[6] Seoul National University,undefined
来源
Health Nanotechnology | / 1卷 / 1期
关键词
Chemotherapy; Liposome; Doxorubicin; Aptamer; MUC1 protein; Cancer cells;
D O I
10.1186/s44301-024-00001-1
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] Targeting Doublecortin-like Kinase 1 (DCLK1) in Colon Cancer: An <it>In</it>-<it>silico</it> Approach
    Parsai, Janhvi
    Crockett, Cooper
    Kimball, Hunter
    Raval, Nipam
    FASEB JOURNAL, 2020, 34
  • [42] Targeting CDK9 in Cancer: An Integrated Approach of Combining In Silico Screening with Experimental Validation for Novel Degraders
    Koirala, Mahesh
    Dipaola, Mario
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2024, 46 (03) : 1713 - 1730
  • [43] Anti-VCAM-1 and Anti-IL4Rα Aptamer-Conjugated Super Paramagnetic Iron Oxide Nanoparticles for Enhanced Breast Cancer Diagnosis and Therapy
    Chinnappan, Raja
    Al Faraj, Achraf
    Rahman, Anas M. Abdel
    Abu-Salah, Khalid M.
    Mouffouk, Fouzi
    Zourob, Mohammed
    MOLECULES, 2020, 25 (15):
  • [44] Apoptotic Effects of Mucin1 Aptamer-Conjugated Nanoparticles Containing Docetaxel and c-Met siRNA on SKBR3 Human Metastatic Breast Cancer Cells
    Zolbanin, Naime Majidi
    Jafari, Reza
    Majidi, Jafar
    Atyabi, Fatemeh
    Yousefi, Mehdi
    Jadidi-Niaragh, Farhad
    Zangbar, Mohammad-Sadegh Soltani
    Asadi, Milad
    Nayebi, Alireza Mohajjel
    JUNDISHAPUR JOURNAL OF NATURAL PHARMACEUTICAL PRODUCTS, 2019, 14 (04)
  • [45] Screening of phytochemicals as potential anti-breast cancer agents targeting HER2: an in-silico approach
    Lamichhane, Sudarshan
    Rai, Raj Prateek
    Khatri, Amar
    Adhikari, Rajendra
    Shrestha, Bhupal Govinda
    Shrestha, Simon Kumar
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023, 41 (03): : 897 - 911
  • [46] In Silico Screening of Available Drugs Targeting Non-Small Cell Lung Cancer Targets: A Drug Repurposing Approach
    Thirunavukkarasu, Muthu Kumar
    Suriya, Utid
    Rungrotmongkol, Thanyada
    Karuppasamy, Ramanathan
    PHARMACEUTICS, 2022, 14 (01)
  • [47] In Silico Screening Identifies a Novel Potential PARP1 Inhibitor Targeting Synthetic Lethality in Cancer Treatment
    Li, Jian
    Zhou, Nan
    Cai, Peiling
    Bao, Jinku
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (02)
  • [48] Effect of an alkyl spacer on the morphology and internalization of MUC1 aptamer-naphthalimide amphiphiles for targeting and imaging triple negative breast cancer cells
    Kuang, Huihui
    Schneiderman, Zachary
    Shabana, Ahmed M.
    Russo, Gabriella C.
    Guo, Jun
    Wirtz, Denis
    Kokkoli, Efrosini
    BIOENGINEERING & TRANSLATIONAL MEDICINE, 2021, 6 (01)
  • [49] In Silico Screening of Marine Compounds as an Emerging and Promising Approach against Estrogen Receptor Alpha-Positive Breast Cancer
    Alamri, Abdulwahab
    Rauf, Abdur
    Khalil, Anees Ahmed
    Alghamdi, Adel
    Alafnan, Ahmed
    Alshammari, Abdulrahman
    Alshammari, Farhan
    Malik, Jonaid Ahmed
    Anwar, Sirajudheen
    BIOMED RESEARCH INTERNATIONAL, 2021, 2021
  • [50] Effect of an alkyl spacer on the morphology and internalization of MUC1 aptamer-naphthalimide amphiphiles for targeting and imaging triple negative breast cancer cells
    Kuang, Huihui
    Schneiderman, Zachary
    Shabana, Ahmed M.
    Russo, Gabriella C.
    Guo, Jun
    Wirtz, Denis
    Kokkoli, Efrosini
    Bioengineering and Translational Medicine, 2021, 6 (01):